Biocon
Biocon
| Biocon | |
| Création | 1978 |
|---|---|
| Dates clés | Kiran Mazumdar-Shaw |
| Fondateurs | Kiran Mazumdar-Shaw |
| Action | National Stock Exchange (BIOCON)[1] |
| Siège social | Bengalore |
| Directeurs | Kiran Mazumdar-Shaw |
| Activité | Biotechnologie |
| Produits | Médicament biologique |
| Filiales | Biocon (Switzerland) (d) |
| Effectif | 5 585 |
| Site web | www.biocon.com |
| modifier - modifier le code - voir Wikidata | |
Biocon est une entreprise indienne de biotechnologie, basée à Bengalore. Elle est fondée par Kiran Mazumdar-Shaw. Elle est notamment spécialisée dans les enzymes, la fabrication d'insuline ou l'oncologie[2].
Histoire
En , Biocon annonce l'acquisition des activités de médicaments biosimilaires de Viatris pour 3,34 milliards de dollars[3].
Références
- ↑ Knowledge Graph (graphe de connaissances), consulté le .
- ↑ Biocon, la biopharma indienne qui défie les big pharmas, Mathilde Eslida, Tribune, 19 avril 2014
- ↑ (en) « India's Biocon beefs up biosimilar portfolio with $3.34 bln Viatris deal, shares fall », sur Reuters,
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.